C. Maresca

发表

Interleukin-34 Mediates Cross-Talk Between Stromal Cells and Immune Cells in the Gut

I. Marafini, E. Franzè, E. Troncone, 2022, Frontiers in Immunology.

Targeting IL-34/MCSF-1R Axis in Colon Cancer

I. Marafini, E. Troncone, G. Monteleone, 2022, Frontiers in Immunology.

Hepcidin Upregulation in Colorectal Cancer Associates with Accumulation of Regulatory Macrophages and Epithelial–Mesenchymal Transition and Correlates with Progression of the Disease

V. Formica, G. Strimpakos, I. Monteleone, 2022, Cancers.

Rafoxanide sensitizes colorectal cancer cells to TRAIL-mediated apoptosis.

G. Sica, I. Monteleone, G. Monteleone, 2022, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

Targeted Therapy of Interleukin-34 as a Promising Approach to Overcome Cancer Therapy Resistance

C. Stolfi, E. Franzè, G. Monteleone, 2023, Cancers.

Implication of Intestinal Barrier Dysfunction in Gut Dysbiosis and Diseases

G. Monteleone, F. Laudisi, C. Stolfi, 2022, Biomedicines.

GATA6 deficiency leads to epithelial barrier dysfunction and enhances susceptibility to gut inflammation.

A. Desideri, E. Lolli, I. Monteleone, 2021, Journal of Crohn's & colitis.

A novel tumour enhancer function of Insulin-like growth factor II mRNA-binding protein 3 in colorectal cancer

G. Sica, I. Monteleone, G. Monteleone, 2023, Cell Death & Disease.

An essential role of adenosine deaminase acting on RNA 1 in coeliac disease mucosa

O. Paoluzi, I. Monteleone, G. Monteleone, 2023, Frontiers in Immunology.

Smad7 Sustains Stat3 Expression and Signaling in Colon Cancer Cells

G. Sica, I. Monteleone, G. Monteleone, 2022, Cancers.

SMAD7 Sustains XIAP Expression and Migration of Colorectal Carcinoma Cells

I. Monteleone, F. Laudisi, G. Monteleone, 2024, Cancers.